Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 13,647 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 13,647 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the transaction, the director owned 68,188 shares in the company, valued at approximately $1,705,381.88. This trade represents a 16.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Privia Health Group Price Performance

PRVA stock opened at $23.81 on Wednesday. The firm has a 50 day simple moving average of $24.44 and a two-hundred day simple moving average of $22.81. The stock has a market cap of $2.93 billion, a PE ratio of 183.17, a P/E/G ratio of 4.20 and a beta of 0.83. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The firm had revenue of $213.61 million for the quarter. On average, research analysts expect that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

Large investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. raised its holdings in Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares in the last quarter. CWM LLC increased its position in shares of Privia Health Group by 89.4% during the second quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after buying an additional 1,612 shares during the period. Canada Pension Plan Investment Board increased its position in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the period. Raymond James Financial Inc. bought a new position in Privia Health Group in the second quarter worth about $113,000. Finally, Covestor Ltd lifted its stake in shares of Privia Health Group by 39.8% in the 3rd quarter. Covestor Ltd now owns 5,824 shares of the company’s stock valued at $145,000 after purchasing an additional 1,657 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

PRVA has been the subject of a number of research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research note on Monday. Canaccord Genuity Group lifted their price objective on Privia Health Group from $32.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, November 12th. BMO Capital Markets assumed coverage on Privia Health Group in a research note on Thursday, November 13th. They issued an “outperform” rating and a $30.00 price target on the stock. JMP Securities increased their price objective on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, August 29th. Finally, Evercore ISI raised their target price on shares of Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $30.42.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.